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ditorialadiation  oncology  in Latin speaking  countries:  A link
etween Europe  and  Latin  America.  Introduction
he network of international collaboration in science tradi-
ionally has been dominated by English speaking countries,
ut this network is rapidly expanding at the global level.
etween 40 and 50 countries appear in the center of the inter-
ational network in 2011, and almost all nations are nowadays
nvolved in international collaboration.1
The origin of Romance languages is Vulgar Latin spoken by
he commoners of the Roman Empire. After its fall and frag-
entation in the ﬁfth century, the different languages evolved.
eginning in the 15th century, they expanded to other conti-
ents due to the Portuguese, Spanish, and French empires.
Therefore, Latin-speaking Europe is considered as the area
f Europe where Romance languages are either ofﬁcial, co-
fﬁcial, or signiﬁcantly used. It is a major linguistic subdivision
f Europe alongside Germanic- and Slavic-speaking subdi-
isions. The Latin European countries are mainly France,
taly, Portugal, and Spain. It also includes some regions
rom other countries, such as Wallonia in Belgium and
he French- and Italian-speaking cantons of Switzerland as
ell as communities from other non-Romance European
ountries. Some Eastern Romance languages like Aromanian,
egleno-Romanian and Istro-Romanian are spread across the
ntire Balkans in small communities within Slavic-speaking
ountries, Greece and the European part of Turkey. The total
opulation of all the Romance speaking areas in Europe is
pproximately 190,000,000.
Spain and France are major players in the network in terms
f international coauthorship relations. The polar position of
pain and France is noteworthy and can be considered as a
onsequence of their leading position in collaborations with
editerranean and Romance language speaking countries.1
espite the nearly global use of English as the language
f research publication, there are still distinct collaborative
roupings of Luso-/Hispanophone nations in Central and
outh America and Francophone countries in Africa.2 These
etworks point to cultural and economic factors underlying
egional differentiation in the global patterns.1Latin America is a wide region that includes 41 countries
located in North, Central, and South America and the
Caribbean region. The estimated population for 2013 is
approximately 593 million. Ninety-seven percent of the pop-
ulation speaks Spanish or Portuguese, 64% speaks Spanish
and 33% Portuguese, two languages fully intelligible between
them.3–7
Spain and Portugal have remained a hub between the
EU and Latin America.8 Indeed, Presmanes and Zumelzu9
reported that coauthorship relations among South American
countries are less developed than those between some of these
Latin American countries and Spain. Countries with languages
other than Spanish or Portuguese are peripheral to this net-
work as are some nations in Central America.1
This special issue provides a brief overview of the current
state of radiation oncology in Latin speaking countries and the
outlook for the future.
2.  Basic  research:  method,  environment,
and  opportunity
Great progress has been made in recent years in both clinical
and translational research. This is important because research
is essential for the continuing development of all medical
specialties. Clinical research is a key, because it promotes an
environment of scientiﬁc excellence and quality within our
daily practice, while translational investigation obliges radia-
tion oncologists to become more  deeply involved in the ﬁeld.
Although many  Latin speaking radiation oncologists are
involved in research promoted by international research
groups such as the Radiation Therapy Oncology Group (RTOG)
or the European Organization for Research and Treatment of
Cancer (EORTC), there is room for improvement in both clin-
ical and laboratory research among Latin speaking countries.
We need to make a much greater effort to coordinate research
and to expand our participation in international projects. At
present, it is safe to say that collaboration and teamwork
among Latin speaking countries is not the norm, perhaps in
part due to the lack of infrastructure and resources.
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3.  New  technologies  and  special
techniques  for  radiotherapy
Teixeira10 evaluated the situation of radiotherapy in Latin
America in 1990. Consultation was made with representatives
of 10 countries, resulting in the responses from 5 of them.
These ﬁve countries represent approximately 80% of the total
area and population of South America. At that time, Linacs
only represented one-third of all machines used for external
beam radiotherapy in South America. Therefore, the cobalt
machine was the basic megavoltage equipment.
Like other medical specialties with a large technological
component, continuous technological advances require con-
stant adaptation. All new technologies in radiation oncology
have the same aim: to improve the precision, dose and control
of radiation to the target to improve tumor control without
increasing treatment-related side effects. By now, many  of
these new technologies have become standard in larger radio-
therapy centers: arc therapy, image-guided radiation therapy
or stereotactic ablative radiotherapy.
The introduction of new treatment techniques and tech-
nology has clearly been very positive for patients and
physicians alike. Numerous new techniques, increasingly
more advanced machines, and other improvements have
made radiotherapy faster and more  effective. However, the
emergence of new technologies can be a double-edged
sword. The technological advancement tends to turn pro-
fessionals into mechanical robots as they are compelled to
become highly mechanized and bureaucratized. We agree
with Zietman,11 the current president of the American Society
of Radiation Oncology (ASTRO), who stated: “if radiation onco-
logists become simply the guardians of a single therapeutic
modality they may ﬁnd that time marches by and, while the
techniques will live on, the specialty may not”.
In the light of the changes in technology, the ever-
increasing access of developing countries to such technology,
and its current coverage in Latin America, any efforts in this
area should be aimed at improving the quality of the radiothe-
rapy departments and centers that are already in place. This
involves developing their technological assets to the fullest,
expanding the services that the departments offer, and com-
plying with the minimum quality requirements established
for second-level facilities. Each center should be equipped to
carry out all stages of the radiotherapy process, from simu-
lation through treatment veriﬁcation and patient follow-up,
with a high level of quality. To achieve this, it should possess
both the necessary technology and properly trained staff,
required for this purpose. Collaborative efforts should also
prioritize helping countries implement national treatment
standards for all stages of the radiotherapy process and pro-
moting the implementation of validated quality assurance
programs.12
4.  Current  challenges  and  conclusionsRadiation oncology has come a long way over the years, and
is now an important and well-established specialty in cancer
care. However, many  challenges still remain and we must beiotherapy 1 9 ( 2 0 1 4 ) 227–229
prepared to face them. One of the major problems resulting
from advances in medical treatment using radioactive sources
is that frequently equipment is developed and bought by hos-
pitals before they have the trained staff needed to handle it.
Aspects of this issue have been examined by a panel of experts
brought together in Latin America by the International Atomic
Energy Agency (IAEA).
New cancer cases per year were expected to have risen from
600,000 to 790,000 in Latin America in the decade 1990–2000,
which is an increase of 30%.4 Around 100 more  teletherapy
machines are needed according to IAEA,5 which implies an
increase of 14%. Therefore, health service deﬁciencies in this
area are commonly attributed to a shortfall of equipment. One
of the major problems, which is not often highlighted, is that
high-tech therapy is often associated with a high cost and,
therefore, not always widely available.13 Nevertheless, it is
important to remind that the underuse of radiotherapy should
be a matter of concern, given its negative and measurable
impact on the survival of patients.14
The White Book of Radiation Oncology, published by the
Spanish Society of Radiation Oncology (SEOR),13 provides a
comprehensive overview of the current state of the specialty in
Spain and the outlook for the future. The book, which includes
contributions from more  than 50 professionals, was written
as a reference for physicians, health-care administrators and
hospital managers. This book could be used as a starting point
for other Latin speaking countries to provide a comprehen-
sive overview of the present-day situation of the specialty of
radiation oncology in Latin speaking countries and could be a
useful source for radiation oncologists and administrators of
the health care system, as well as for hospital managers.
Teaching programs are insufﬁcient or inexistent in cer-
tain areas. Common training programs would help avoid this
situation. The European young radiation oncology societies
based in Spain (Spanish Young Radiation Oncology Group,
SYROG) and France (French Society of Young Radiation Onco-
logists, SFJRO) could be a platform for developing this task. The
main objective of these groups is to motivate young specialists
and promote scholarly activity in national and international
meetings. These societies also promote understanding among
young specialists of the importance of receiving adequate
training according to international standards. In addition,
these groups instigate and help young specialists to obtain
international training and potentially set up new national and
international protocols in the ﬁeld of radiation oncology.15,16
The Latin language is a bridge between Europe and Latin
America, but both continents must continue to strengthen
that role. Latin speaking countries should be open to collab-
orate with other international scientiﬁc societies, not only
within Europe and Latin America, but also with others out-
side the Latin borders of the speaking world such as those in
North America and Asia.
To conclude, the aim of this editorial is to highlight the rel-
evancy of Latin speaking countries in international research
and to illustrate what could be accomplished if Latin speak-
ing researchers apply their knowledge, skills, and resources
in a focused way. There is no reason why we  should not be
at the forefront of research and publishing in our respective
areas of expertise.17 The opportunity to provide leadership on
a wider world stage is available, but it is up to us to seize the
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nitiative, to expand our horizons and, above all, to act with
nergy, passion, and conviction.
onﬂict  of  interest
one declared.
inancial  disclosure
one declared.
 e  f  e  r  e  n  c  e  s
1. Leydesdorff L, Wagner C, Park HW, Adams J. International
collaboration in science: the global map and the network. El
Profesional de la Información 2013;22:87–94.
2. Adams J, King C, Hook D, editors. Global research report: Africa.
Leeds, UK: Evidence Thomson Reuters; 2010.
3. Economic Commission for Latin America and the Caribbean
(CEPALECLAC). Statistical yearbook for Latin America and the
Caribbean 2002. Santiago de Chile: CEPAL-ECLAC, United
Nations; 2003.
4. Ferlay J, Parkin DM, Pisani P. Globocan 1: cancer incidence and
mortality worldwide (on CD-ROM). Lyon: IARC, WHO; 1998.
5. International Atomic Energy Agency. Design and
implementation of a radiotherapy programme: clinical, medical
physics, radiation protection and safety aspects (TECDOC 1040).
Vienna: IAEA; 1998.
6. International Monetary Fund. World economic and ﬁnancial
surveys: world economic outlook database. Washington, DC:
International Monetary Fund; 2004.
7. Países de América Latina por población. Retrieved January
2013 from http://es.wikipedia.org/wiki/Anexo:Pa%C3
%ADses de Am%C3%A9rica Latina por poblaci%C3%B3n
8. Glänzel W,  Leta J, Thijs B. Science in Brazil, part 1: a
macro-level comparative study. Scientometrics 2006;67:
67–86.
9. Presmanes B, Zumelzu E. Scientiﬁc cooperation between
Chile and Spain: joint mainstream publications (1991–2000).
Scientometrics 2003;58:547–58.
0. Teixeira LC. Situation of radiotherapy in Latin America. Int J
Radiat Oncol Biol Phys 1990;19:1267–70.
1. Zietman A. Semin Radiat Oncol 2008;18:207–13.therapy 1 9 ( 2 0 1 4 ) 227–229 229
2. Castellanos ME. New technologies: needs and challenges in
radiotherapy in Latin America. Rev Panam Salud Publica
2006;20:143–50.
3. Bentzen SM. High-tech in radiation oncology: should there be
a ceiling? Int J Radiat Oncol Biol Phys 2004;58:320–30.
4. Tovar I, Expósito J, Jaén J, Alonso E. Underuse of radiotherapy
in  lung cancer has negative consequences for patients. J
Thorac Oncol 2013;8:62–7.
5. SEOR. Libro Blanco de la SEOR: Análisis de la situación,
necesidades y recursos de la oncología radioterápica. Spain:
EDIMSA 2010 Madrid; 2011.
6. Lopez Guerra JL, Isa N, Kim MM, Bourgier C, Marsiglia H. New
perspectives in radiation oncology: young radiation
oncologist point of view and challenges. Rep Pract Oncol
Radiother 2012;17:251–4.
7. Guedea F, Ferrer M. Spanish researchers at the forefront of
clinical investigation: the case of quality of life in prostate
cancer. Clin Transl Oncol 2009;11:403–4.
J.L. Lopez Guerra ∗
Virgen del Rocío University Hospital, Department of Radiation
Oncology, Seville, Spain
E. Rivin
Department of Radiation Oncology, Institut de cancérologie
Gustave Roussy, Villejuif, Paris, France
F. Guedea
Department of Radiation Oncology, Institut Català d’Oncologia,
L’Hospitalet de Llobregat, Barcelona, Spain
M.J. Ortiz
Virgen del Rocío University Hospital, Department of Radiation
Oncology, Seville, Spain
∗ Corresponding author at: Department of Radiation Oncology,
Virgen del Rocío University Hospital, Manuel Siurot Avenue
s/n, 41013 Seville, Spain. Tel.: +34 95 501 2105;
fax: +34 95 501 2111.
E-mail address: chanodetriana@yahoo.es (J.L. Lopez Guerra)
1507-1367/$ – see front matter
© 2013 Greater Poland Cancer Centre. Published by Elsevier
Urban & Partner Sp. z o.o. All rights reserved.
http://dx.doi.org/10.1016/j.rpor.2013.06.004
